The multifocal nature of prostate cancer has necessitated whole-gland therapy in the past; however, since the widespread use of PSA screening, patients frequently present with less-advanced disease.

Share on Pinterest There are a variety of tests that can be used to diagnose prostate cancer. SDI Productions/Getty Images The standard practice for diagnosing prostate cancer includes an MRI test and ...

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

The modern approach to AS was first described in 1995, and numerous programs have now reported follow-up outcomes at 5 years and beyond. 8 In Toronto, Klotz et al 5 initiated a program of AS aimed at ...

68 Ga-PSMA PET/MRI examples of PRIMARY scores. T2WI = T2-weighted image; PZ = peripheral zone; CZ = central zone. Reston, VA—PET/MRI can improve diagnostic accuracy for prostate cancer patients and ...

An interview with Dr. Anil Parwani, discusses how whole slide imaging of prostate cancer sections is helping to inform pathologists and improve patient outcomes. Prostate cancer is often a devastating ...

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers? It is also noteworthy that patients can ...

The antibody 7E11 binds to the intracellular epitope of PSMA and can reach this only when the cell membrane is damaged. In this case, the tumor on the right was irradiated; the left one was not. The ...

The approval of Posluma will help clinicians determine the extent of disease in men with prostate cancer and possible management options. The Food and Drug Administration (FDA) approved Posluma ...

The US Food and Drug Administration (FDA) has approved flotufolastat fluorine-18 (Posluma), a radiopharmaceutical for use with positron-emission tomography (PET) in prostate cancer. The product is ...

The Food and Drug Administration has approved a new imaging agent to detect prostate cancer after it has spread to other parts of the body. Experts say the tracer, made by medical imaging company ...